Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  guadecitabine
Find trials that include:  Any drugs shown
Results 1-5 of 5 for your search:
Start Over
Guadecitabine and Irinotecan Hydrochloride or Regorafenib or TAS-102 Alone in Treating Patients with Previously Treated Metastatic Colorectal Cancer
Status: Active
Phase: Phase II, Phase I
Type: Treatment
Age: 18 and over
Trial IDs: NA_00085870, J1369, NCI-2013-02005, j1369, NA_00085870, CIR00004735, CIR00013885, CIR0002117, NCT01896856
DNA Methyltransferase Inhibitor SGI-110 with or without Idarubicin or Cladribine in Treating Older Patients with Previously Untreated Acute Myeloid Leukemia
Status: Active
Phase: Phase II
Type: Treatment
Age: Over 70
Trial IDs: 2013-0843, NCI-2014-00981, NCT02096055
Guadecitabine in Treating Patients with Higher-Risk Myelodysplastic Syndromes
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 2013-0901, NCI-2014-02377, NCT02131597
Guadecitabine and Donor Lymphocyte Infusion in Treating Patients with Acute Myeloid Leukemia or Myelodysplastic Syndrome Relapsing after Allogeneic Stem Cell Transplant
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 to 75
Trial IDs: 2015-0117, NCI-2016-00343, NCT02684162
DNA Methyltransferase Inhibitor SGI-110, Donor GVAX and Cyclophosphamide in Treating Patients with Metastatic Colorectal Cancer
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: J13138, NA_00087578, NCI-2014-00919, J13138, NA_00087578, NCT01966289
Start Over